References
- Sturdee DW, Panay N; International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–522.
- Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010;67:233–238.
- Lachowsky M, Nappi RE. The effects of oestrogen on urogenital health. Maturitas 2009;63:149–151.
- Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003:CD001500.
- Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M, Ravarino N, et al. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol 2010;26:404–412.
- Machin D, Campbell MJ. Statistical tables for the design of clinical trials. Boston: Blackwell Scientific Publications; 1987.
- Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas 2004;49:292–303.
- North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14 (3 Pt 1):355–69; quiz 370–371.
- Caillouette JC, Sharp CF Jr, Zimmerman GJ, Roy S. Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 1997;176:1270–5; discussion 1275.
- Clarkson TB, Utian WH, Barnes S, Gold EB, Basaria SS, Aso T, Kronenberg F, et al., for the NAMS/Utian Isoflavone Translational Symposium. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause 2010 18;732–53.
- Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 1998;12:605–623.
- Palacios S, Rojo IA, Cancelo MJ, Neyro JL, Castelo-Branco C. Women’s perception of the efficacy of a soy extract with probiotic: the M3 study. Gynecol Endocrinol 2008;24:178–183.
- Caputi AP, Arcoraci V, Benvenuti C, Estronet Study Group. Soy isoflavones, lactobacilli, vitamin D3 and calcium. Observational study in menopause. Gior It Ost Gin 2006;XXVIII:212–21.
- Mucci M, Carraro C, Mancino P, Monti M, Papadia LS, Volpini G, Benvenuti C. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol 2006;58:323–334.
- Agosta C, Atlante M, Benvenuti C, Estronet Study Group. Randomized controlled study on clinical efficacy of isoflavones plus Lactobacilli, associated or not with a natural anxiolytic agent in menopause. Minerva Ginecol 2011;63:1–7.
- Tempfer CB, Froese G, Heinze G, Bentz EK, Hefler LA, Huber JC. Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med 2009;122:939–46.e9.
- Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 2008;7:17.